← Back to Search

Peer Support for Inflammatory Bowel Disease Distress

N/A
Recruiting
Research Sponsored by Jennifer Jones
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult IBD patient (18 years or older)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 8
Awards & highlights
No Placebo-Only Group

Summary

This trial will study IBD Strong Peer, an evidence-based, peer-led intervention to help people with IBD-related psychological distress. It will provide implementation & effectiveness data to improve & adapt the intervention to local needs.

Who is the study for?
This trial is for adults over 18 with Inflammatory Bowel Disease (IBD) who are newly diagnosed, switching from child to adult care, experiencing a flare-up or medication change, recently hospitalized, or preparing for surgery. It's not suitable for those outside these criteria.
What is being tested?
The IBD Strong Peer2Peer program is being tested against a waitlist control group. This peer-led virtual support aims to help manage psychological distress in adults with IBD. The study will gather data on how well it works and how it can be improved.
What are the potential side effects?
Since this intervention involves peer-to-peer support rather than medication, traditional side effects aren't expected. However, participants may experience emotional discomfort when discussing personal health challenges.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 or older with inflammatory bowel disease.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 8
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 8 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adherence rate
Attrition rate
Fidelity
+10 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Waitlist -controlsExperimental Treatment1 Intervention
Group II: IBD Strong Peer2Peer interventionExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Jennifer JonesLead Sponsor
2 Previous Clinical Trials
182 Total Patients Enrolled
Crohn's and Colitis CanadaOTHER
7 Previous Clinical Trials
1,187 Total Patients Enrolled
Nova Scotia Health AuthorityOTHER
288 Previous Clinical Trials
94,442 Total Patients Enrolled
~17 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top